US3919302A
Expired / Lapsed
US
⏱️ 0.0 years remaining
11,15 Dimethyl-11 deoxy PGF{HD 2 {B
Assignee: Wyeth LLC
•
Filing: 1974-02-28
•
Granted: 1975-11-11
•
Expires: 1994-02-28
Abstract
Abstract The topical application of 7-(5 Alpha -hydroxy-2 Beta -((3RS)-3hydroxy-3-methyl-trans-1-octenyl)-3 Alpha -methyl-1 Alpha cyclopentyl)-cis-6-heptenoic acid, 7-(5 Alpha -hydroxy-2 Beta ((3RS)-3-hydroxy-3-methyl-trans-1-octenyl)-1 Alpha -cyclopentyl)cis-5-heptenoic acid, or 7-(2 Beta -((3RS)-hydroxy-3-methyltrans-1-octenyl)-5-oxo-1 Alpha -cyclopentyl)-cis-5-heptenoic acid to a wound surface can be employed to attenuate bleeding. The compounds are prepared from the prostaglandin PGA2.
Inventors
- 👤 Donald P Strike
- 👤 Wenling Kao
- 👤 Richard L Fenichel
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-28 14:55
CPC Classifications
C; C07; C07C; C07C405/00
Claims Analysis
Total Claims: 2
Claim 1
Independent Claim
8 words
THE COMPOUND WHICH IS 7-(5A-HYDROXY-2B-((3RS)-3HYDROXY-3-METHYL-TRANS-1-OCTENYL-1-OCTENYL)-3A -METHYL-1A-CYCLOPENTYL) -CIS-5-HEPTENOIC ACID.
Claim 2
Dependent Claim
8 words
THE COMPOUND WHICH IS 7-(5A-HYDROXY-2B-((3RS)-3HYDROXY-3-METHYL-TRANS-1-OCTENYL-1-OCTENYL)-3A -METHYL-1A-CYCLOPENTYL) -CIS-5-HEPTENOIC ACID.
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1978-11-10 | 1979-05-12 | 1979-11-11 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1982-11-10 | 1983-05-12 | 1983-11-11 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1986-11-10 | 1987-05-12 | 1987-11-11 | $7700.00 | Window Closed / Lapsed |